Roschier represented Sanofi in connection with its investment in Vicore

Recent work|October 23, 2024

Roschier has represented Sanofi in connection with Sanofi’s participation in Vicore’s rights issue.

Sanofi has, through a subscription commitment and subsequent subscription of shares in Vicore Pharma Holding AB (“Vicore”) in connection with Vicore’s SEK 782 million rights issue, invested in shares in Vicore corresponding to a total amount of approximately SEK 102 million and 6.21 percent of the shares and votes in Vicore post new issues.

Sanofi is one of the world’s leading biopharmaceutical companies. Vicore is a clinical-stage biopharmaceutical company listed on Nasdaq Stockholm.

Roschier’s advisory team comprised Christoffer Benninge and Tilda Rosengren.